11:17 AM
 | 
Jan 19, 2018
 |  BC Week In Review  |  Company News  |  Deals

ShangPharma, Icahn in R&D deal

ShangPharma Innovation Inc. (South San Francisco, Calif.) will fund preclinical research at the Icahn School of Medicine at Mount Sinai (New York, N.Y.)...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >